Keywords: addendum, gsk, tyverb, april, issue, marketletter, article

Addendum: GSK's Tyverb

Article | 21 April 2008

Print This

In the April 14 issue of a Marketletter article on cancer drug trials being stopped after early signs of efficacy, we ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in